$7.66
0.000.00%
Pre-Market: Jan 17, 4:04 PM EDT
Comments
Loading...
Alumis (NASDAQ:ALMS) Stock Quotes, Forecast and News Summary
Alumis Stock (NASDAQ: ALMS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Alumis (ALMS) stock?
You can purchase shares of Alumis (NASDAQ:ALMS) through any online brokerage.
Who are Alumis (ALMS) competitors?
Other companies in Alumis’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).
What is the forecast, or price target, for Alumis (ALMS) stock?
Alumis has a consensus price target of $29.60.
What is the current price for Alumis (ALMS)?
The stock price for Alumis (NASDAQ: ALMS) is $7.66 last updated January 17, 2025 at 4:04 PM EST.
Does Alumis (ALMS) pay a dividend?
There are no upcoming dividends for Alumis.
When is Alumis (NASDAQ:ALMS) reporting earnings?
Alumis’s Q4 earnings are confirmed for Saturday, February 15, 2025.
Is Alumis (ALMS) going to split?
There is no upcoming split for Alumis.
What sector and industry does Alumis (ALMS) operate in?
Alumis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.